Fig. 6

Hemolytic and blood clotting properties of the fabricated nanofibrous mats (A-D). Hemolytic activities of different groups of nanofibrous mats, blood in pure water were considered as the positive control, and blood solution in normal saline was considered as the negative control (A). Hemolysis percentage after incubation with red blood cells for 60 min at 37 °C (B). The image of the clot of developed nanofibrous mats before and after lysing (B) and BCI percentage of the prepared materials (D). Blood with pure water was chosen as a control group. One-Way ANOVA with Turkey analysis (n = 3; *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001)